UHC Forward: Towards Universal Health Coverage

One controversial component of the Colombian health system is that CR members—the wealthier—receive a richer benefits package than the poorer SR members. The CR benefits package covers all levels of care including inpatient, outpatient, maternity leave, and sick leave. The SR package covers all low-complexity care and catastrophic illnesses but provides only limited coverage for most hospital care and no short term disability coverage. The SR is complemented by services provided by public hospitals, financed through direct payments to providers from the state, independent of what services they supply and of patients’ insurance status.

Entitlements of coverage under the MHIF were introduced under the State Guarantee Benefits Package (SGBP). The specifications of the SGBP are the following:

• Primary care is provided free of charge for the entire population with certain lab and diagnostic tests against copayment.
• Hospital care is provided against formal copayment. Copayment is a flat fee payable upon admission.
• Exemption categories were designed based on categorical targeting and disease types to protect populations with high expected health care use. Providers receive a higher payment for treating exempt patients to prevent selection bias.
• An additional outpatient drug benefit was also introduced to subsidize the price of medicines for primary care sensitive conditions in order to reduce unnecessary hospitalizations (e.g., anemia, ulcers, pneumonia, and hypertension).

The Additional Drug Package (ADP) was introduced in 2000 as a way of reinforcing the importance of primary care. It started in seven pharmacies and was slowly rolled out to the entire country by 2003. The ADP is an outpatient drug benefit for those insured with the MHIF, which initially included 37 generic drugs but has expanded since. To purchase drugs through the ADP, the patient pays a discounted price at the pharmacy and the MHIF reimburses the pharmacy for the difference. The subsidy amount is based on a reference price and is approximately 50% of the reference price.

The benefit package for the National Health Insurance Program began small and was extended incrementally, because extension of population coverage was prioritized over expansion of benefits. Currently, benefits are the same for all insured individuals, regardless of whether they are self-employed or not. Both preventative and curative services are included in the benefits package. Preventative services include biannual check-ups and vaccination. For curative services, the insured are entitled to in-patient and outpatient care, dental services, traditional oriental medicines, and prescription medication. Procedures excluded from coverage include treatment for simple fatigue, superficial dermatology problems, cosmetic surgery, urogenic and gynecological diseases which cause no problems in everyday life, treatment of addiction to narcotics, and orthodontics.

Services are provided without a referral in all non-specialized health centers. To visit a specialized general hospital the patient must have a referral. Co-payments are required for all medical procedures. The amount of co-payment depends on the level of medical care received and whether the procedure was in-patient or out-patient. When an insured individual pays more than the co-payment ceiling—about 3 million Won or $2,400 USD—within 6 consecutive months, he or she is exempted from further co-payments. The co-payments are higher for hospitals than for physician clinics in order to encourage people to visit physician clinics before hospitals.

Table 1: Co-payment system

Source: Song, Young Joo. “The South Korean Health Care System” JMAJ, Vol. 52, No. 3: 207. 2009.

Out of pocket (OOP) expenditures have been reduced drastically since the expansion of health insurance coverage, from 63% of total health expenditure in 1983 to 38% of total health expenditure in 2008. However, despite this improvement, the share of OOP payments is still greater than the OECD average, and some scholars suggest that this is still a substantial barrier to medical care utilization across different socio-economic groups.